1. Home
  2. ADXN vs APVO Comparison

ADXN vs APVO Comparison

Compare ADXN & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADXN
  • APVO
  • Stock Information
  • Founded
  • ADXN 2002
  • APVO 2016
  • Country
  • ADXN Switzerland
  • APVO United States
  • Employees
  • ADXN N/A
  • APVO N/A
  • Industry
  • ADXN Biotechnology: Pharmaceutical Preparations
  • APVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • ADXN Health Care
  • APVO Health Care
  • Exchange
  • ADXN Nasdaq
  • APVO Nasdaq
  • Market Cap
  • ADXN 8.0M
  • APVO 6.5M
  • IPO Year
  • ADXN N/A
  • APVO N/A
  • Fundamental
  • Price
  • ADXN $7.59
  • APVO $3.95
  • Analyst Decision
  • ADXN Strong Buy
  • APVO Strong Buy
  • Analyst Count
  • ADXN 1
  • APVO 1
  • Target Price
  • ADXN $30.00
  • APVO $296.00
  • AVG Volume (30 Days)
  • ADXN 24.6K
  • APVO 46.8K
  • Earning Date
  • ADXN 03-24-2025
  • APVO 03-04-2025
  • Dividend Yield
  • ADXN N/A
  • APVO N/A
  • EPS Growth
  • ADXN N/A
  • APVO N/A
  • EPS
  • ADXN 0.06
  • APVO N/A
  • Revenue
  • ADXN $701,260.00
  • APVO N/A
  • Revenue This Year
  • ADXN N/A
  • APVO N/A
  • Revenue Next Year
  • ADXN N/A
  • APVO N/A
  • P/E Ratio
  • ADXN $1.04
  • APVO N/A
  • Revenue Growth
  • ADXN N/A
  • APVO N/A
  • 52 Week Low
  • ADXN $6.81
  • APVO $3.65
  • 52 Week High
  • ADXN $27.90
  • APVO $399.60
  • Technical
  • Relative Strength Index (RSI)
  • ADXN 48.97
  • APVO 39.61
  • Support Level
  • ADXN $7.20
  • APVO $3.77
  • Resistance Level
  • ADXN $8.04
  • APVO $4.47
  • Average True Range (ATR)
  • ADXN 0.51
  • APVO 0.29
  • MACD
  • ADXN 0.00
  • APVO 0.08
  • Stochastic Oscillator
  • ADXN 47.95
  • APVO 38.40

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment which is the discovery, development and commercialization of small-molecule pharmaceutical products.

About APVO Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.

Share on Social Networks: